| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 316.72B | 298.75B | 317.12B | 348.28B | 342.25B | 289.34B |
| Gross Profit | 39.23B | 39.13B | 39.18B | 32.38B | 33.34B | 34.41B |
| EBITDA | 7.36B | 7.64B | 6.89B | 3.17B | 4.95B | 8.47B |
| Net Income | 3.32B | 4.44B | 3.15B | -1.04B | 478.00M | 2.49B |
Balance Sheet | ||||||
| Total Assets | 88.45B | 108.08B | 105.93B | 108.48B | 101.35B | 104.91B |
| Cash, Cash Equivalents and Short-Term Investments | 12.14B | 16.87B | 11.92B | 12.04B | 10.23B | 10.24B |
| Total Debt | 3.95B | 4.93B | 5.48B | 12.27B | 6.94B | 5.53B |
| Total Liabilities | 33.72B | 47.95B | 50.70B | 55.16B | 47.72B | 50.52B |
| Stockholders Equity | 54.70B | 60.10B | 55.21B | 53.30B | 53.62B | 53.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.61B | 8.26B | -3.38B | -3.71B | -844.00M |
| Operating Cash Flow | 0.00 | 6.59B | 10.53B | -945.00M | 389.00M | 1.13B |
| Investing Cash Flow | 0.00 | 198.00M | -2.76B | -1.67B | -698.00M | 2.15B |
| Financing Cash Flow | 0.00 | -1.80B | -7.59B | 4.28B | 435.00M | -3.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥23.03B | 17.63 | ― | 4.50% | 4.36% | 80.89% | |
69 Neutral | ¥84.22B | 19.05 | ― | 1.37% | -5.79% | 40.68% | |
69 Neutral | ¥222.94B | 11.38 | ― | 3.45% | -7.92% | -6.17% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
64 Neutral | ¥1.68T | 10.98 | 2.23% | 3.07% | -11.80% | 87.51% | |
62 Neutral | ¥3.55T | 14.66 | -0.15% | 2.74% | -4.52% | 19.27% | |
62 Neutral | ¥103.52B | 14.53 | ― | 2.57% | -0.05% | -10.24% |